Carregant...
The Cabilly patents: Status quo and relevance for antibody companies
This article discusses the status quo of the Cabilly patents, their scope of protection and the role these patents play for the therapeutic antibody industry in Europe and the US.
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Landes Bioscience
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3361663/ https://ncbi.nlm.nih.gov/pubmed/22453097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.4.2.19253 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|